SCHEMBL2402205

SCHEMBL2402205

CS(=O)(=O)c1ccc(S(=O)(=O)NC2CCC(C(=O)N3CCN(C4CCCC4)CC3)CC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
DRD2 P14416 1/20 0.50
ADRA1D P25100 1/20 0.50
ADRA1A P35348 1/20 0.50
ADRA1B P35368 1/20 0.50
DPP4 P27487 3/20 0.49
DPP7 Q9UHL4 3/20 0.49
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
POLB P06746 1/20 0.47
KDM4E B2RXH2 1/20 0.46
RECQL P46063 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CHRM2 P08172 1/20 0.44
CHRM1 P11229 1/20 0.44
LMNA P02545 1/20 0.44
HPGD P15428 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2402209 1.00 ALDH1A1 (0.50) ALDH1A1DRD2ADRA1DADRA1AADRA1B
SCHEMBL2401119 0.98 ALDH1A1 (0.50) ALDH1A1DRD2ADRA1DADRA1AADRA1B
SCHEMBL2401122 0.98 ALDH1A1 (0.50) ALDH1A1DRD2ADRA1DADRA1AADRA1B
SCHEMBL2400636 0.89 KMT2A (0.61) ALDH1A1MEN1KMT2APOLBKDM4E
SCHEMBL2400630 0.89 KMT2A (0.61) ALDH1A1MEN1KMT2APOLBKDM4E
SCHEMBL2405879 0.87 KMT2A (0.58) ALDH1A1MEN1KMT2APOLBSMN1; SMN2
SCHEMBL2405877 0.87 KMT2A (0.58) ALDH1A1MEN1KMT2APOLBSMN1; SMN2
SCHEMBL2401449 0.86 IRAK4 (0.52) ALDH1A1MEN1KMT2APOLBHPGD
SCHEMBL2399850 0.86 TRPV4 (0.51) ALDH1A1DPP4DPP7MEN1KMT2A
SCHEMBL2399848 0.86 TRPV4 (0.51) ALDH1A1DPP4DPP7MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8017773-B2 Cyclohexyl sulfonamide derivatives HOFFMANN-LA ROCHE INC. (US) 2011-09-13 US disclosed
CN-101370779-B Cyclohexyl sulfonamide derivatives having H3 receptor activity HOFFMANN LA ROCHE 2011-07-20 CN disclosed
EP-1979322-B1 CYCLOHEXYL SULFONAMIDE DERIVATIVES HAVING H3 RECEPTOR ACTIVITY HOFFMANN LA ROCHE (CH) 2010-09-01 EP disclosed
US-20100120791-A1 CYCLOHEXYL SULFONAMIDE DERIVATIVES NETTEKOVEN MATTHIAS 2010-05-13 US disclosed
CN-101370779-A Cyclohexyl sulfonamide derivatives having H3 receptor activity HOFFMANN LA ROCHE (CH) 2009-02-18 CN disclosed
EP-1979322-A1 CYCLOHEXYL SULFONAMIDE DERIVATIVES HAVING H3 RECEPTOR ACTIVITY F.HOFFMANN-LA ROCHE AG (CH) 2008-10-15 EP disclosed
WO-2007082840-A1 CYCLOHEXYL SULFONAMIDE DERIVATIVES HAVING H3 RECEPTOR ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2007-07-26 WO disclosed
US-20070173511-A1 Cyclohexyl sulfonamide derivatives F. HOFFMANN-LA ROCHE AG (CH) 2007-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120791-A1 CYCLOHEXYL SULFONAMIDE DERIVATIVES HRH3, HRH4, HRH1 ALDH1A1 430/4885DRD2 1307/4885ADRA1D 154/4885
US-20070173511-A1 Cyclohexyl sulfonamide derivatives HRH3, HRH4, HRH1 ALDH1A1 430/4885DRD2 1307/4885ADRA1D 154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.